SCHEMBL11903484

SCHEMBL11903484

FC(F)(F)Oc1ccc2nc(Cc3ccc4c(c3)CCCC4)[nH]c2c1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.49
GRIN1 Q05586 6/20 0.46
GRIN2B Q13224 6/20 0.46
TRPV1 Q8NER1 2/20 0.44
CBFB Q13951 3/20 0.44
RUNX1 Q01196 3/20 0.44
CACNA1B Q00975 1/20 0.43
BACE1 P56817 1/20 0.43
SCN10A Q9Y5Y9 1/20 0.42
MAOB P27338 1/20 0.41
RAD52 P43351 1/20 0.40
UBE2N P61088 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11903482 0.91 GRIN1 (0.41) PDE10AGRIN1GRIN2BTRPV1CACNA1B
Hydrochloric Acid SCHEMBL11903476 0.81 GRIN1 (0.53) PDE10AGRIN1GRIN2BTRPV1CBFB
Hydrochloric Acid SCHEMBL11903456 0.80 GRIN1 (0.65) PDE10AGRIN1GRIN2BTRPV1CBFB
Hydrochloric Acid SCHEMBL11903596 0.79 GAA (0.61) PDE10AGRIN1GRIN2BTRPV1CBFB
SCHEMBL11903493 0.76 RUNX1 (0.58) PDE10ATRPV1CBFBRUNX1SCN10A
SCHEMBL10284557 0.76 PDE10A (0.58) PDE10AGRIN1GRIN2BTRPV1CBFB
SCHEMBL11903504 0.74 PDE10A (0.62) PDE10AGRIN1GRIN2BTRPV1CBFB
SCHEMBL15819760 0.73 TRPV1 (0.52) TRPV1
SCHEMBL11904659 0.73 PDE10A (0.55) PDE10AGRIN1GRIN2BTRPV1CBFB
Hydrochloric Acid SCHEMBL11903522 0.72 PDE10A (0.67) PDE10AGRIN1GRIN2BTRPV1CBFB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293780-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making U.S. DEPARTMENT OF ENERGY (US) 2012-10-23 US disclosed
US-8242284-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 2012-08-14 US disclosed